Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world’s first treatment to slow the progression of Parkinson’s disease.
A groundbreaking study by researchers at Wuhan University, China, has identified a cholesterol metabolite that plays a crucial role in the progression of Parkinson’s disease. The findings, publishe…